HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gloyn, A. L. Articles by Hattersley, A. T. Search for Related Content PubMed PubMed Citation Articles by Gloyn, A. L. Articles by Hattersley, A. T. Social Bookmarking                What's this?

Maturity-Onset Diabetes of the Young Caused by a Balanced Translocation Where the 20q12 Break Point Results in Disruption Upstream of the Coding Region of Hepatocyte Nuclear Factor-4 (HNF4A) Gene

¹ Department of Diabetes and Vascular Medicine, University of Exeter, Exeter, U.K.
² Regional Cytogenetics Centre, Southmead Hospital, Bristol, U.K.
³ School of Biological Sciences, University of Wales, Swansea, U.K.
⁴ Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.

Monogenic human disorders have been used as paradigms for complex genetic disease and as tools for establishing important insights into mechanisms of gene regulation and transcriptional control. Maturity-onset diabetes of the young (MODY) is a monogenic dominantly inherited form of diabetes that is characterized by defective insulin secretion from the pancreatic ß-cells. A wide variety of mutation types in five different genes have been identified that result in this condition. There have been no reports of a chromosome deletion or translocation resulting in MODY. We report a pedigree where MODY cosegregates with a balanced translocation [karyotype 46, XX t(3;20) (p21.2;q12)]. The chromosome 20 break point, 20q12, is within the region of one of the known MODY genes, hepatocyte nuclear factor-4 (HNF4A). Fluorescence in situ hybridization analysis demonstrated that the break point does not disrupt the coding region of this gene, but it lies at least 6 kb upstream of the conventional promoter (P1). We propose that this mutation disrupts the spatial relationship between the recently described alternate distal pancreatic promoter (P2) and HNF4A. This is the first case of MODY due to a balanced translocation, and it provides evidence to confirm the crucial role of an upstream regulator of HNF4A gene expression in the ß-cell.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				J. Ek, S. P. Hansen, M. Lajer, C. Nicot, T. W. Boesgaard, S. Pruhova, A. Johansen, A. Albrechtsen, K. Yderstraede, J. Lauenborg, et al. A Novel -192c/g Mutation in the Proximal P2 Promoter of the Hepatocyte Nuclear Factor-4{alpha} Gene (HNF4A) Associates With Late-Onset Diabetes Diabetes, June 1, 2006; 55(6): 1869 - 1873. [Abstract] [Full Text] [PDF]

				H. Raeder, L. Bjorkhaug, S. Johansson, K. Mangseth, J. V. Sagen, A. Hunting, I. Folling, O. Johansen, M. Bjorgaas, P. N. Paus, et al. A Hepatocyte Nuclear Factor-4{alpha} Gene (HNF4A) P2 Promoter Haplotype Linked With Late-Onset Diabetes: Studies of HNF4A Variants in the Norwegian MODY Registry Diabetes, June 1, 2006; 55(6): 1899 - 1903. [Abstract] [Full Text] [PDF]

				C. Bellanne-Chantelot, S. Clauin, D. Chauveau, P. Collin, M. Daumont, C. Douillard, D. Dubois-Laforgue, L. Dusselier, J.-F. Gautier, M. Jadoul, et al. Large Genomic Rearrangements in the Hepatocyte Nuclear Factor-1{beta} (TCF2) Gene Are the Most Frequent Cause of Maturity-Onset Diabetes of the Young Type 5 Diabetes, November 1, 2005; 54(11): 3126 - 3132. [Abstract] [Full Text] [PDF]